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Lung  macrophages (LM)'  are  known  to differ from peritoneal  macrophages 
(PM)  in  many respects,  such  as their  lysosomal enzymes,  metabolic activity for 
energy  requirement,  morphology,  and  function  (1-3).  We  reported  that  the 
expression  of a  glycosphingolipid,  asialo  GM1,  on  the  cell  surface  is  markedly 
different between LM and PM (4,  5). 
In  the  present  paper,  we  report  that  LM  are  unresponsive  to activation  for 
tumor  cytotoxicity  by  bacterial  lipopolysaccharide  (LPS),  while  PM  from  the 
same strains of mice were responsive, because of the  lack of binding  with  LPS 
on the cell surface of LM. The LPS-binding sites appear after treatment of LM 
in  vitro  with  a  lymphokine-rich  supernatant  or  recombinant  murine  gamma 
interferon (IFN-y), resulting in recovery of responsiveness to activation by LPS. 
Materials and  Methods 
Animals.  Female  C3H/HeSlc,  BALB/cSIc,  and  ICR/Slc  mice  were  obtained  from 
Shizuoka Experimental Animal Cooperative (Hamamatsu, Japan), and C3H/HeNCrj were 
from Charles River Japan, Inc. (Atsugi, Japan). Mice (6-8-wkold) were housed in a specific 
pathogen-free condition before use. 
Reagents.  LPS (phenol extract from Escherichia coli 055:B5) and LPS conjugated with 
fluorescein isothiocyanate (FITC-LPS) (molar ratio,  24:1) were obtained from List Bio- 
logical Laboratories, Inc. (Campbell, CA).  Insoluble concanavalin A (Con A-Sepharose) 
and indometbacin were obtained from Sigma Chemical Co. (St.  Louis, MO). Polymixin B 
sulfate was obtained from P-L Biochemicals, Inc. (Milwaukee, WI). 
Recombinant  Murine IFN-'t.  Recombinant murine IFN-% obtained from gene expres- 
sion in Escherichia coli (6), was agift from Toray Industries, Inc. (Tokyo, Japan). Amino 
acid sequence encoded by the IFN-~, gene used is identical to that of the natural murine 
IFN-y gene (personal communication, Toray Industries, Inc.). Specific activity of the IFN- 
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q, was 8.3  X  106  U/mg, and a  stock solution of 1 x  105  U/ml contained <0.05  ng/ml 
endotoxin as determined by the Limulus amebocyte lysate test. 
Antisera.  Rabbit anti-mouse IFN-~' and IFN-(a +/3) antisera were obtained from Enzo 
Biochem, Inc. (New York, NY). The number of neutralizing units of the anti-mouse IFN- 
y  was 50,000 against mouse IFN-~', and <16 against mouse IFN-~ and -/3. The number 
of neutralizing units of anti-mouse IFN-(c~ +/3) was 28,000 against mouse IFN-(a +/3) or 
mouse IFN-/3,  10,000 against mouse IFN-a, and <16 against mouse IFN-5,. 
Culture Medium.  RPMI  1640  medium  was  prepared  from powdered  stock  (Nissui 
Seiyaku, Co., Ltd., Tokyo) and supplemented with  100  U/ml of penicillin G  potassium 
(Banyu Seiyaku Kabushiki Kaisha, Tokyo) and  100 ug/ml of streptomycin sulfate (Meiji 
Seika Kaisha, Yokohama, Japan). Fetal bovine serum (FBS) (Lot 309, Gibco Laboratories, 
Grand Island, NY) was inactivated at 56°C  for 30 rain before use. The FBS contained 
0.013 ng/ml of LPS according to the test with Limulus amebocyte lysate (Gibco Labora- 
tories). RPMI 1640 medium was further supplemented with 5% FBS and used as culture 
medium unless otherwise stated (FBS-RPM| medium). For preparing lymphokines, RPMI 
1640  medium  was  supplemented  with  10%  Nuserum  (Collaborative  Research,  Inc., 
Lexington, MA) (Nu-RPMI medium). 
Preparation of Macrophages.  Peritoneal resident cells (PRC) were obtained by washing 
out  normal  mouse  peritoneal  cavities with  physiologic saline.  Peritoneal  exudate  cells 
(PEC) were obtained from mice that had received an intraperitoneal (i.p.)  injection of 2 
ml of 10%  proteose-peptone  3  d  before.  Lung cells (LC) were prepared as previously 
described  (4).  Briefly,  the  lungs  were  chopped  into  1-2-mm  squares,  after  vascular 
perfusion with Ca  ++ and Mg++-free phosphate-buffered saline (PBS) containing 10 U/ml 
of heparin to avoid blood cell contamination,  until the lung tissue was uniformly white. 
LC were washed out from the cut pieces with PBS containing 0.05% EDTA and the cells 
were filtered through a 200-mesh stainless steel sieve. Alveolar cells (AC) were harvested 
by bronchial lavage. The trachea was exposed and an 18-gauge catheter was inserted into 
the  trachea  between  two  rings  of cartilage.  The  lavage  fluid  (PBS  containing  0.05% 
EDTA) was introduced in 0.8-ml amounts from a  1 ml syringe connected to the catheter, 
the chest cavity was gently massaged, and the lavage fluid was withdrawn from the lungs 
into the syringe. A total of 2.4 ml of lavage fluid per mouse was used. 
PRC, PEC, LC, and AC were washed three times by centrifugation and resuspended 
in ice-cold RPMI 1640 medium. Total cell counts were made with a hemocytometer, and 
cells were differentiated by using cell smears of a Diff-Quik Stain Set (Harleco, a division 
of American Hospital Supply Corp., Gibbstown, N  J). 0.1-ml quantities of a cell suspension 
containing 2 X 106 macrophages/ml were pipetted into wells of 96-well flat-bottom tissue 
culture  plates (Falcon  No.  3072;  Becton  Dickinson & Co.,  Oxnard,  CA),  or,  80-90-~1 
quantities of a  cell  suspension  containing  2  x  106  macrophages/ml were spotted onto 
coverslips (15-mm diam). They were incubated at 37 °C for 120 min, and nonadherent 
cells were removed by repeated washing with physiologic saline solution. At least 96% of 
the adherent cells were macrophages as judged by morphologic and phagocytic criteria 
(4, 5), and they were used as macrophage monolayers of peritoneal resident macrophages 
(PRM),  peritoneal  exudate  macrophages (PEM),  lung  macrophages (LM),  or  alveolar 
macrophages (AM). 
Crude Lymphokines (LK).  Spleen  cells  from normal  ICR/SIc mice were obtained  by 
extrusion  of  the  spleens  through  a  200-mesh  stainless  steel  sieve  and  washed  with 
physiologic saline solution three times. The cells were suspended in RPMI 1640 medium 
and treated with 3 vol of 0.5% ammonium chloride to lyse red blood cells. The cells were 
washed twice and suspended in Nu-RPMI medium. 10 ml of the spleen cell suspension (1 
x  107 cells/ml) were incubated with 100 ~g]ml of Con A-Sepharose at 37°C for 48 h in 
plastic tissue culture dishes (Falcon No. 3003) according to the method of Fidler et al. (7) 
with slight modification. The culture supernatant was harvested by centrifugation at 500 
g for 20 rain at 4°C, then filtered through a 0.45-~m Miilipore filter (Millex-HA; Millipore 
Corp., Bedford, MA) and stored at -70°C (crude  LK). The culture supernatant of the 
spleen cells alone and Con A-Sepharose without cells were used as controls. 
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10 (Millipore  Corp.),  and  then  fractionated on a  1.5  X  90 cm Sephacryl S-200 column 
(Pharmacia Fine Chemicals, Uppsala, Sweden) that was previously equilibrated with 0.15 
M  PBS (pH 7.2).  The column was operated at a flow rate of 25 ml/h, and calibrated by 
using as markers,  bovine serum  albumin  (67,000  mol wt),  ovalbumin (43,000  tool wt), 
Blue  Dextran  2000,  catalase  (232,000  tool  wt)  (Pharmacia  Fine  Chemicals),  and  cyto- 
chrome c (12,500 mol wt) (Boehringer Mannheim GmbH, Mannheim,  Federal Republic 
of Germany).  Fractions  were  collected  and  protein  was  quantitated  by measuring  the 
absorption at 280 nm. 
Activation  of Macrophages.  Procedures of macrophage activation with LK or LPS were 
described previously (5). Briefly, macrophage monolayers prepared in 96-well plates were 
preincubated for various time periods with  200 #1 each of either  LK or LPS at selected 
concentrations, and then washed twice with physiologic saline. 
Assay for Tumor Cytotoxicity.  The assay method was described previously (5).  Briefly, 
cells (5  x  106/0.5  ml) of an  EL4 leukemia  cell line,  established  in this laboratory, were 
incubated with 50 uCi of Na2 ~lCrO4 (New England Nuclear, Boston, MA) for 50 min at 
37°C and washed three  times and suspended  in  FBS-RPMI medium.  200 #1 of labeled 
EL4 cell suspension containing 1 X  104 cells were added to the macrophage monolayers, 
and incubated for 20 h. The plates were then centrifuged for 10 min at 350 g and 100 #1 
of the supernatant was removed from each well for counting radioactivity on an automatic 
gamma spectrometer.  All samples were assayed in triplicate.  Cytotoxicity was expressed 
as percent specific 5~Cr release calculated from the average of triplicate samples as follows: 
percent specific release =  (experimental release -  spontaneous release)/(maximum release 
-  spontaneous  release).  Spontaneous  release  was taken  as  the  amount  of radioisotope 
released from target cells cultured alone, and maximal release was the amount obtained 
by treatment with 2% Nonidet P-40 (Sigma Chemical Co.). 
Assay  of Direct  Toxic  Effect  of LPS  on  Macrophages.  The  killing  effect  of LPS  on 
macrophages was assayed by the method of Glode et al. (8).  Briefly, macrophage mono- 
layers prepared  in  96-well  plates  were  incubated  with  FBS-RPMI  medium  containing 
various concentrations of LPS in the presence or absence of crude LK (1:10 dilution) for 
40 h. The supernatants were decanted and replaced with 0.1 ml of0.15 M saline containing 
0.3%  trypan  blue  dye.  200  cells  were  scored  for viability on the  basis  of trypan  blue 
exclusion, and the mean of triplicate cultures was obtained.  The results are expressed as 
the percentage of dead macrophages relative to total cells. 
Measurement of Binding of FITC-LPS to Macrophages.  Binding of FITC-LPS to macro- 
phages was determined by a fluorescence microscope or by flow cytometry. 40 #1 of FITC- 
LPS (100 #g/ml) suspended in PBS containing 0.1% NaN3 was spotted on the macrophage 
monolayers prepared on coverslips. The coverslips were held at 0°C for 60 min, washed, 
and then dipped into wells containing PBS supplemented with  1% paraformaldehyde.  In 
some experiments, FITC-LPS was preincubated with various concentrations ofpolymyxin 
B for 30 rain at 37 °C. The number of cells stained with FITC-LPS was determined with 
a  fluorescence  microscope.  The  results  were  expressed  the  percentage  of cells  stained 
with FITC-LPS among a total of 200 cells. 
For the flow cytometry analysis, PC and LC (2 X  106) were mixed with 300 #1 of FITC- 
LPS (100  ug/ml)  suspended  in  PBS  containing  0.1%  NAN3,  held  at  0°C  for  60  min, 
washed three times with ice-cold PBS, and resuspended in PBS. Cell-bound fluorescence 
was analyzed on a  fluorescence-activated cell sorter  (FACS 440;  Becton  Dickinson  Im- 
munocytometry Systems, Mountain  View, CA) using an argon ion laser (model  !64-06, 
400 roW; Spectra-Physics, Inc., Mountain View, CA) at 488 nm excitation.  Fluorescence 
was measured through a 530-nm-long pass filter. The fluorescence data of LM in LC and 
of PRM in PC were obtained by the use of the dual scatter (0 ° and 90 °  scatter) gate to 
exclude most cellular debris,  dead cells, erythrocytes, and lymphocytes and to maximize 
macrophage detection.  Fluorescence  intensity  was expressed  on  linear  scale.  For each 
experiment, at least  1 x  104 cells were analyzed to yield the histogram shown. AKAGAWA  AND  TOKUNAGA  1447 
Results 
LPS-induced Tumor Cell Killing.  PRM, PEM, LM, and AM from C3H/HeSlc 
mice were incubated at 37 °C for 20 h either with various concentrations of LPS 
or  with  medium alone,  washed, and  then  assayed for tumor cytotoxicity. As 
shown in  Fig.  1,  PEM  preincubated with LPS showed strong cytotoxicity; 0.1 
ug/ml of LPS was sufficient to induce a high level of cytotoxicity. PRM prein- 
cubated with LPS showed less  but significant levels of cytotoxicity, which was 
dependent upon the dose of LPS.  LM and AM, in contrast, did not show any 
cytotoxicity after incubation with LPS at any concentration. LM and AM were 
incubated with LPS at increasing doses up to 100 ug/ml, for various incubation 
periods from 4 to 48 h, and then cytotoxicity was tested at increasing ratios of 
effector-to-target cells up to 30.  However, these LM and AM showed no cyto- 
toxicity (data not shown). In one experiment, LM were incubated with 10 ug/ml 
of LPS for 20 h and then tested for cytotoxicity in the presence of 10 ug/ml of 
LPS, but no cytotoxic activity was observed. 
Effect  of Indomethacin  on  Activation  of LM  by LPS.  Prostaglandins of the  E 
series (PGE) are known to inhibit macrophage activation (9,  10). It is possible 
that the unresponsiveness of LM or AM to LPS is caused by a large amount of 
PGE produced by LPS-stimulated LM or  AM.  To test this possibility, a  PGE 
inhibitor, indomethacin, was added together with LPS to LM or PRM. As shown 
in Table I, indomethacin (10 -6 M) greatly augmented the cytotoxicity of PRM 
stimulated with LPS. In contrast, LM stimulated with LPS showed no cytotox- 
icity, regardless  of the  presence  of indomethacin.  These  results  exclude  the 
possibility mentioned above. 
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FIGURE  1.  Tumor cell killing by LM, AM, PRM, and PEM incubated with LPS. Monolayers 
of LM  (/~),  AM (F-I), PRM  (O), and  PEM  (C)) were incubated with various concentrations of 
LPS for 20 h at 37°C, washed, and assayed for cytotoxicity against 5~Cr-labeled EL4 cells. 1448  LIPOPOLYSACCHARIDE RECEPTOR  ON  MOUSE LUNG  MACROPHAGES 
TABLE  I 
Effect of lndomethacin on the Activation of LM and PRM by LPS 
Treatment 
Cytotoxicity (mean ___ SD) 
LM  PRM 
% 
Medium  -1.6 4- 2.0  -1.6 -  0.8 
10 ug/ml LPS  2.1 4- 0.8  10.1 4- 1.7 
1 gg/ml LPS  1.3 4- 1.6  6.4 4- 2.3 
0.1 #g/ml LPS  1.8 4- 1.9  4.9 4- 1.4 
Medium + indomethacin  0.8 4- 1.1  2.0 + 0.5 
10 #g/ml LPS + indomethacin  1.3 4- 1.9  36.8 4- 0.9 
1 ~g/ml LPS + indomethacin  1.6 4- 1.7  22.9 --- 1.1 
0.1 ~g/ml LPS + indomethacin  2.1 4- 1.2  7.7 4- 2.1 
LM and PRM were incubated with medium alone or various con- 
centrations of LPS for 20 h with or without indomethacin (10  -6 
M). Cells were washed and assayed for cytotoxicity, lndomethacin, 
when it was added, existed during the cytotoxicity  test. The results 
are  expressed as  the  mean percentage  of triplicate cultures  + 
standard deviation. 
Synergistic Effect of Crude LK and LPS on Activation of  LM.  It has been reported 
(11-13)  that  PEM  from  C3H/HeJ,  A/J,  and  P/J  mice  fail  to  develop  tumor 
cytotoxicity after LPS stimulation, but that they develop cytotoxicity when they 
are pretreated with  LPS plus  LK. Therefore, we tested  the effect of crude LK 
on  activation  of LM  by LPS.  Monolayers of LM  were incubated  with  various 
concentrations of LPS in  the presence or absence of various dilutions of crude 
LK  for  20  h  at  37°C.  The  cells  were  washed  and  then  assayed  for  their 
cytotoxicity. Incubation of LM with any concentrations of the crude LK alone 
or  of  LPS  alone  did  not  evoke  cytotoxicity  (Fig.  2).  However,  concurrent 
incubation with crude LK and LPS rendered LM cytotoxic in a  dose-dependent 
fashion. Increasing the concentration of crude LK caused a  progressive shifting 
of the LPS dose response curve toward lower LPS concentrations. The minimum 
concentration  of LPS required  for cooperation with  crude  LK (1:10  dilution) 
was as small as  1 ng/ml. The culture supernatants of spleen cells alone and Con 
A-Sepharose  alone,  used  as  controls,  did  not  show  such  an  effect  (data  not 
shown).  Similar  to  LM,  AM  incubated  with  LPS  and  crude  LK  concurrently 
evoked cytotoxicity (data not shown). 
The activation of LM was found to be critically dependent on the sequence of 
treatment  with  LK  and  LPS.  Monolayers  of LM  were  incubated  with  either 
crude LK (1:10 dilution),  LPS (1  #g/mi), crude LK plus LPS, or medium alone 
for 14 h at 37°C, and washed. They were incubated further with either of these 
agents for 10 h at 37 °C. The cells were washed and then assayed for cytotoxicity. 
LM treated first with crude LK and then with LPS were cytotoxic (Table II), as 
were  LM  treated  with  crude  EK plus  LPS for 24 b.  LM treated  with  medium 
alone  first and  then  treated  with  crude  LK plus  LPS showed almost the  same 
degree  of cytotoxicity.  In  contrast,  LM  treated  first  with  LPS  and  then  with 
crude  LK  showed  no  cytotoxicity. Thus,  LM  exposed  to  crude  LK  were  not 
cytotoxic but became sensitive to subsequent stimulation with LPS. The reverse AKAGAWA  AND  TOKUNAGA  1449 
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FIGURE 2.  Synergistic effect of crude LK and LPS on tumor cytotoxicity of LM. Monolayers 
of LM were incubated with various concentrations of LPS in the presence of various dilutions 
of crude LK (O,  1:10 dilution; A,  1:30 dilution; I-1, 1:90 dilution) or medium (O) for 20 h  at 
37°C, washed, and then assayed for cytoto×icity against ~lCr-labeled EL4 cells. 
TABLE  II 
Effect of Sequence of Treatment with Crude LK and LPS on the 
Activation  of LM  for Cytotoxicity 
Treatment  Cytotoxicity 
First 14 h  Second  10 h  (mean +  SD) 
% 
Medium  Medium  -2.0 +-- 0.8 
LK  LK  1.0 -  1.5 
LPS  LPS  1.2 +  2.3 
LK plus LPS  LK plus LPS  23.0 +  2,1 
LK  LPS  17.7 +- 2,6 
LPS  LK  -2.0 +  3.1 
Medium  LK  --1.6 -- 2.5 
Medium  LPS  0.1  --- 0.8 
Medium  LK plus LPS  21.6 +_ 2.9 
LM were incubated with either crude LK (1:10 dilution), LPS (1 ~g/ml), 
or medium alone for  14 h, and washed. The LM were incubated further 
with either of these agents for 10 h. Those cells were washed and assayed 
for  cytotoxicity.  The  results are  expressed  as  the  mean  percentage  of 
triplicate cultures +  standard deviation. 
sequence  of treatment  of LM  with  LPS and  crude  LK was completely  ineffective. 
These  experiments  were  repeated  with  PRM  and  LM  from  BALB/cSlc,  ICR/ 
Slc,  and  C3H/HeNCrj  mice;  results  were  similar  to  those  obtained  with  C3H/ 
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TABLE III 
Effect of Pretreatment of Crude LK with Rabbit Anti-Mouse IFN-~ or 
IFN-(c~ + 13) Antiserum 
LM incubated with:  Cytotoxicity 
% 
Medium  0.9 -  1.3 
LPS  0.8 +  1.6 
LK  -6.3 + 3.5 
LK treated with anti-|FN-')"  -2.6 -  1.9 
LK treated with anti-IFN-(c~  +/3)  -4.9 + 2.8 
LPS plus EK  33.9 -+ 1.8 
EPS plus LK treated with anti-IFN-3'  3.3 -+ 3.2 
LPS plus LK treated with anti-IFN-(c~  +/3)  25.6 -+ 3.5 
Crude  LK was preincubated  with either  rabbit  anti-lFN-3, or -(o~ +  /3) 
antiserum or medium alone for 60 rain at 37°C. LM were incubated with 
either of these preincubated  crude LK (1:20 dilution) together with or 
without LPS (1 ug/ml) at 37°C for 20 h, washed, and assayed for cytotox- 
icity. The  results  are  expressed  as  the  mean  percentage  of triplicate 
cultures + standard deviation. 
Active Fraction in  Crude LK.  Gel  filtration  of crude  LK by Sephacryl  S-200 
column chromatography was performed.  LM were incubated  for 20 h  at  37°C 
with some of the  fractions eluted  from the  column,  in  the presence of 1 #g/ml 
of LPS,  and  then  assayed for their  cytotoxicity.  The  results  indicated  that  the 
molecular weights of active components were distributed broadly, ranging from 
~40,000  to 70,000  (data not shown).  The activity of the macrophage-activating 
factor  (MAF)  contained  in  the  same  fractions  was  determined  by  using  PEM. 
PEM were incubated for 20 h  with those fractions in the presence of 3 ng/ml of 
LPS and assayed for their cytotoxicity. The fractions showing MAF activity were 
also distributed broadly, ranging from about 40,000  to 70,000  mol wt (data not 
shown). 
Recent  studies  indicate  that  IFN-3' has potent  MAF activity (14-16).  There- 
fore, crude LK was incubated with rabbit anti-mouse IFN-3, or IFN-(~ +/3) for 
60  min  at  37°C.  The  IFN  titer  of the  crude  LK  was  159  U/ml  before  the 
incubation,  though  the  type of IFN  was not  determined.  Anti-IFN-3' and  anti- 
IFN-(0~ +  /3)  were able  to  neutralize  200  U  of IFN-~, and  IFN-/3,  respectively. 
After incubation,  all the samples were diluted  (1:20) and tested for their ability 
to render  LM  cytotoxic in  the  presence of LPS  (1  #g/ml).  LM  incubated with 
the crude LK pretreated with anti-IFN-(oz +/3) plus LPS showed strong cytotox- 
icity  (Table  III), as  did  LM  incubated  with  LPS  plus  nontreated  crude  LK. 
However,  LM  incubated  with  crude  LK pretreated  with  anti-IFN-3' plus  LPS 
showed no cytotoxicity. 
Effect  of  Treatment  with  Recombinant  Murine  IFN-3,  on  Activation  of LM  by 
LPS.  The results described above suggest that the molecule contained in crude 
LK that renders LM responsive to LPS is IFN-3'. Since the anti-IFN-3, antiserum 
used was polyclonal  we tested  the effect of recombinant murine  IFN-3, instead 
of crude LK. LM were incubated with  1 to 1 x  10 ~ U/ml of recombinant murine 
IFN-3' in  the  presence  or absence of various concentrations  of LPS,  for 20  h, 
washed, and then assayed for their cytotoxicity. LM treated with the IFN-3' alone AKAGAWA  AND  TOKUNAGA 
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FIGURE  3.  Effect of recombinant murine IFN-~' on activation of LM by LPS. Monolayers of 
LM were incubated with various concentrations of LPS in the presence of various concentra- 
tions of recombinant murine IFN-~' (O,  103 U/ml; A,  102 U/rnl; A,  10 U/ml; [3,  1 U/ml) or 
medium (@) for 20 h at 37°C, washed, and then assayed for cytotoxicity against ~lCr-labeled 
EL4 cells. 
did not show cytotoxicity (Fig. 3), but LM treated with the IFN-~ plus LPS did. 
10 or more units of the IFN-3, per milliliter rendered LM cytotoxic, depending 
on the doses of LPS. 
Lethal Toxicity of LPS for PRM, PEM, and LM.  Lethal toxicity of LPS for LM, 
PRM, and PEM was investigated by incubating these cells with 10-100 #g/ml of 
LPS for 40  h  at  37°C.  As  indicated in Table IV,  PRM  and  PEM  were highly 
sensitive to LPS toxicity; 21.0% of PRM and 16.4% of PEM died when incubated 
with  10 ug/ml  of LPS. On  the other hand,  LM were resistant  to LPS toxicity, 
and  only a  negligible  population  of LM  died  from as  high  a  concentration  of 
LPS  as  100  ~g/ml.  However,  when  LM  were  incubated  with  crude  LK  or 
recombinant  murine  IFN-~,,  LM  became  sensitive  to  LPS  toxicity.  PRM  and 
PEM  treated with crude LK also became hyperreactive to LPS toxicity. Crude 
LK or the IFN-3' alone were not toxic to these macrophages. 
Binding of FITC-LPS on the Surface of LM, AM, PRM, and PEM.  To test the 
possibility that the unresponsiveness of LM to LPS was due to the lack of LPS- 
binding sites, we examined the binding of FITC-LPS to LM. The test results by 
fluorescence microscopy are shown in Table V. >90%  of PRM  and  PEM  were 
stained with FITC-LPS, whereas <5% of LM and AM were stained. The intensity 
of fluorescence of PEM was weaker than that of PRM. To exclude the possibility 1452  LIPOPOLYSACCHARIDE  RECEPTOR  ON  MOUSE  LUNG  MACROPHAGES 
TABLE  IV 
Lethal Toxicity of LPS  for LM, PRM, and PEM 
Treatment  Quantity 
Dead cells 
LM  PRM  PEM 
#g/ml  % 
Medium  1.7  2.7  2.1 
LK  1.7  3.4  2.9 
LPS  100  2.4  47.5  28.1 
LPS  50  2.0  26.5  23.4 
LPS  10  1.7  21.0  16.4 
LK +  LPS  100  15.8  60.3  42.6 
LK +  LPS  50  17.8  60.1  50.5 
LK +  LPS  10  17.8  72.5  51.3 
IFN-3'  2.4  2.6  ND 
IFN-'y +  LPS  100  29.0  ND  ND 
IFN-'y +  LPS  50  33.1  ND  ND 
IFN-'~, +  LPS  25  25.5  56.9  ND 
LM, PRM, and PEM were incubated with LPS, crude LK (1:10 dilution), 
recombinant routine IFN-'y (100 U/ml), or LPS plus either crude LK or 
IFN-3', for 40 h. Cell death was measured by the trypan blue dye exclusion 
test. ND, not determined. 200 cells per well were examined for viability, 
and the results are expressed as the mean percentage of dead cells in three 
wells. 
TABLE  V 
Binding of FITC-LPS With or Without Pretreatment With Polymyxin 
B on the Surface  of LM, AM, PRM, and PEM 
Pretreatment of FITC-LPS  Cells stained with  Cells  with polymyxin B  FITC-LPS 
% 
LM  -  3.9 
AM  -  4.6 
PRM  -  98.0 
+  (50 ug/ml)  89.8 
+  (100 ttg/ml)  39.2 
+  (200 ug/ml)  4.7 
PEM  -  90.9 
+  (200 ug/ml)  7.5 
Macrophages on coverslips were incubated with FITC-LPS  (100 ug/ml) 
suspended in PBS in the presence or absence of various concentrations of 
polymyxin B for 60 rain at 0°C. 200 cells on one coverslip were examined, 
and the results are expressed as the mean percentage of cells stained with 
FITC-LPS out of 600 cells. 
that  the  binding  of  LPS  to  the  ceils  is  nonspecific,  we  examined  FITC-LPS 
preincubated  with polymyxin  B  for  30 min  at 37°C.  The  percentage  of PRM  or 
PEM  stained  with  FITC-LPS  decreased  markedly  depending  upon  the  dose  of 
polymyxin  B  (Table  V). 
Preincubation  of  LM  with  crude  LK  or  recombinant  murine  IFN-q;  for  120  h 
rendered  LM  able  to  bind  with  FITC-LPS  (Table  VI).  Pretreatment  of  crude 
LK  with anti-IFN-'~  destroyed  the activity of crude  LK,  while pretreatment  with AKAGAWA AND  TOKUNAGA  1453 
TABLE  VI 
Binding of LPS on the Surface of LM Treated with Crude LK or 
Recombinant Murine IFN-'y 
Cells stained 
Preincubation of LM with:  with FITC- 
LPS 
% 
Medium  3.5 
Crude LK  69.5 
Crude LK pretreated with anti-IFN-3,  10.3 
Crude LK pretreated with anti-IFN-(c~  +/3)  62.9 
IFN-3,  60.8 
LM were incubated with crude LK (1:5 dilution),  IFN-~, (100 U/ml), or 
medium alone for 20 h, washed, and stained with FITC-LPS (100 ug/ml) 
for 60 min at 0°C. Crude LK was preincubated with either rabbit anti- 
IFN-? or rabbit anti-IFN-(a +  /3) for 60  min at 37°C. Anti-IFN-? and 
anti-IFN-(ce  +/3) were able to neutralize 200 U of IFN-3~  and IFN-(c~  + 13), 
respectively.  200 cells per coverslip were examined, and the results are 
expressed as the mean percentage of cells stained with FITC-LPS out of 
600 ceils. 
TABLE  VII 
Binding of FITC-LPS in the Presence and Absence of Polymyxin B on 
the Surface of LM Preincubated  with Recombinant  Murine IFN-'y 
Pretreatment of FITC-LPS  Cells stained with 
LM preincubated with:  with polymyxin B  FITC-LPS 
Medium 
IFN-? 
% 
-  3.5 
+ (100 t~g/ml)  3.1 
+ (200 ug/ml)  1.2 
-  59.1 
+ (100 #g/ml)  2.2 
+ (200 #g/ml)  1.5 
LM  were  incubated with  recombinant murine IFN-? (100  U/ml)  or 
medium alone for 20 h, washed, and stained with FITC-LPS (100 ug/ml) 
suspended in PBS in the presence or absence of various concentrations  of 
polymyxin B for 60 rain at 0°C. 200 cells per culture were examined, and 
the results  are expressed  as the  mean percentage of cells stained  with 
FITC-LPS of triplicate cultures. 
anti-IFN-(o~ +  /3)  did  not change it.  The  fluorescence intensity of LM  treated 
with  crude  LK  or  IFN-3'  was  weaker  than  that  of  PRM.  In  the  presence  of 
polymyxin B, the binding of FITC-LPS to the surface of IFN-~,-treated LM was 
completely abolished  (Table  VII).  In  addition,  FITC-LPS  binding to  IFN-~,- 
treated LM was inhibited in the presence of unlabeled LPS to an equal or greater 
degree than was binding to PRM or PEM (Table VIII). 
The  binding of FITC-LPS  to  LM  or  PEM  was analyzed by flow cytometry. 
Fig.  4  shows the  histogram of LM and PRM.  Almost all of PRM  were stained 
with  FITC-LPS,  while  LM  contained  few  fluorescent  cells.  The  intensity of 
autoflurorescence of LM incubated with PBS alone was significantly higher than 
that of PRM. Analysis of the labeled cell fractions (channels beyond 94) indicated 1454  LIPOPOLYSACCHAR1DE  RECEPTOR  ON  MOUSE  LUNG  MACROPHAGES 
TABLE  VIII 
Binding of FITC-LPS in the Presence or Absence of Unlabeled LPS 
on the Surfaces of LM Treated with Recombinant Murine IFN-% and 
of PRM and PEM 
Presence of  Ceils stained 
Ceils  unlabeled  with FITC- 
LPS  LPS 
% 
LM treated with IFN--¢  -  60.8 
+  3.0 
PRM  -  98.1 
+  22.0 
PEM  -  85.6 
+  18.9 
Macrophages on the coverslips were stained with FITC-LPS (100/~g/ml) 
suspended in PBS in the presence or absence of cold LPS (10 mg/ml) for 
60  min at 0°C.  LM were preincubated with recombinant routine IFN-3' 
(100  U/ml) for 20 h  at  37°C.  200  cells per culture were  examined, and 
the data are expressed as the mean percentage of cells stained with FITC- 
LPS of triplicate cultures. 
that  the  percentage  of labeled  cells  was  90%  for  PRM  and  5.1%  for  LM, 
respectively. These results indicate that PRM and PEM bound LPS on their cell 
surface, while LM and AM did not, and that in vitro treatment of LM with crude 
LK or  recombinant murine  IFN-~' induced binding sites  for LPS on  the cell 
surface. 
Kinetics of the effect of IFN-7 on the appearance of LPS-binding sites on LM 
was examined.  During the  first 6  h  after incubating with  IFN-~'  (100  U/ml), 
binding of FITC-LPS did not increase; but, after 8 h, 30.3%  of the cells  were 
stained (Fig. 5). Thereafter, the percentage of the cells stained with FITC-LPS 
increased gradually and reached a maximum after 48 h. 
Discussion 
LM are known to differ from PM in various characteristics (1-5). The present 
data reveal  that,  under assay conditions in  which  10  t~g/ml  of LPS rendered 
either PRM or PEM strongly cytotoxic, LM and AM never responded to LPS. 
Experimental manipulation in effector-to-target cell ratios, increasing doses of 
LPS to  100  ~g/ml, or various periods of incubation with LPS from 4  to 48  h, 
never evoked cytotoxic activity. 
It has been reported (9,  10) that the cytotoxicity of PM induced with LPS is 
augmented by indomethacin, because indomethacin prevented the synthesis of 
PGE produced by the LPS-stimulated PM. However, this was not the case with 
LM; the addition of indomethacin (10 -6  M),  which markedly augmented the 
cytotoxicity of LPS-stimulated PRM, had no influence on the unresponsiveness 
of LM to LPS (Table I). The amounts of PGE produced in the culture superna- 
tants of LM and PRM stimulated by LPS were measured by the radioimmunoas- 
say technique. The results (unpublished data) showed that LM incubated with 
LPS produced a  negligible amount of PGE,  while  PRM  incubated with  LPS 
produced a very large amount of PGE. AKAGAWA  AND  TOKUNAGA  1455 
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FIGURE  4.  Fluorescence histogram from FACS analysis of LM and PRM labeled with FITC- 
LPS. PC and LC were incubated with FITC°LPS or with PBS at 0°C for 60 min and washed. 
Flow cytometry of LC or PC was performed on FACS using the dual scatter gate to exclude 
contaminating cellular debris, dead cells, erythrocytes, and lymphocytes, and to maximize LM 
or PRM detection. The histograms show fluorescence profiles of LM and PRM. 
It has been reported that there are some particular mouse strains (C3H/HeJ, 
A/J, and P/J) whose PEM cannot be activated by LPS (11-13).  In contrast, we 
observed no difference in LPS unresponsiveness of LM from the mouse strains 
tested  (C3H/HeSIc,  BALB/cSlc,  ICR/Slc,  and  C3H/HeNCrj).  On  the  other 
hand, PEM from C3H/HeJ, A/J, and P/J mice developed cytotoxic activity if the 
cells were incubated with LPS plus LK (11-13).  PEM from an LPS-responsive 
mouse strain, C3H/HeN, showed a similar synergistic effect of LK and LPS on 
macrophage activation (17-19).  As shown in the text, we found a  remarkable 
synergistic effect of LPS  and  crude  LK on  the  activation of LM  for  tumor 
cytotoxicity. In addition, we found that the sequence of treatment of LM with 
LK and LPS was critical, as was also true for PEM from C3H/HeJ, A/J, and P/J 
mice. Only LM treated first with crude LK and then with LPS were activated to 
kill  tumor cells.  It has been  suggested that the genetic basis  for the defect of 
tumoricidal capacity of PEM of C3H/HeJ is either closely linked or identical to 
the Lps gene (11,  21), but the defects of PEM  from A/J and P/J appear to be 
independent of the Lps gene (12,  22).  The PEM of C3H/HeJ are not killed by 1456  LIPOPOLYSACCHARIDE  RECEPTOR  ON  MOUSE  LUNG  MACROPHAGES 
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FZGt~RE 5.  Time course of binding of FITC-LPS on the surface of LM incubated with IFN- 
3'.  LM  on  coverslips were  incubated  with  1FN-3,  (100  U/ml)  (e)  or  medium alone  (©)  for 
various time periods,  washed, and then  stained with  FITC-LPS  (100  ~g/ml)  for  60  min at 
0°C.  200 cells per sample were examined, and the results are expressed as mean percentages 
of triplicate samples. 
LPS in vitro (8) whereas PEM from A/J and P/J were killed. In this point, LM 
are phenotypically similar to PEM of C3H/HeJ mice (Table IV).  However, the 
unresponsiveness of C3H/HeJ PEM is not due to the lack of LPS binding (23, 
24), in contrast to LM. 
Fluorescence microscopic studies showed that neither LM nor AM were stained 
with  FITC-LPS,  while >90%  of PRM  and  PEM  were  stained  (Table  V).  In 
addition, FACS analysis showed that LM do not express binding sites with LPS. 
The binding of FITC-LPS onto LM was restored by treatment with either crude 
LK or  IFN-3'  (Table  VI  and  VII).  Given  that no binding of FITC-LPS onto 
PRM-, PEM-, and IFN-3'-treated LM was seen in the presence of polymyxin B, 
which is known to form a  stable molecular complex with the lipid A region of 
LPS (25) and to block the effect of LPS (26), and given that binding was inhibited 
also by the presence of cold LPS, it seems that the binding of FITC-LPS to these 
cells  is  not  due  to  nonspecific attachment but  rather  to  binding to  the  LPS 
receptor. Confirmation of this requires the quantification of binding sites by, for 
example, Scatchard analysis using an isotopically labeled LPS. 
The  molecular  weight  of the  factor  in  the  crude  LK  that  rendered  LM 
responsive to LPS was roughly estimated by the elution profile of Sephacryl S- 
200 chromatography as ~40,000-70,000.  MAF activity was detected in almost 
the same fractions, in agreement with other findings (18).  Recently (14-16),  it 
was indicated that IFN-3,  has MAF activity. In our experiment, the activity of 
crude LK rendering LM responsive to LPS was neutralized by rabbit anti-IFN- 
3/antiserum but not by rabbit anti-IFN-(~ +  /3) antiserum. This suggested that 
the active molecule in the crude LK was IFN-3'. This was confirmed by the fact 
that IFN-3' could replace crude LK to render LM responsive to LPS (Fig.  3). AKAGAWA AND  TOKUNAGA  1457 
Recently (manuscript in  preparation),  we  found that not only IFN-3' but also 
murine  IFN-/3  and  recombinant  human  IFN-a  A/D  are  able  to  induce  the 
responsiveness of LM to LPS. The mechanism by which the expression of LPS- 
binding sites on  LM  is  triggered by IFN-7  is unclear.  The fact that  LM lack 
expression of LPS-binding sites does not exclude the possibility that LM possess 
other defect(s) in tumoricidal capacity, such as in the pathway of signal transmis- 
sion after LPS binding. Further studies are required on the events occurring in 
LM within 8 h after IFN treatment (Fig. 5). 
The responsiveness of LM to LPS has been found to vary in different animal 
species.  Our  results are  consistent with a  report  that demonstrated a  lack of 
specific binding of LPS to rabbit AM (27).  LM from rats (28)  or humans (29) 
can be activated by LPS. We observed (unpublished data) that LM from SD rats 
were activated by LPS and that ~70% of them were stained with FITC-LPS. In 
mice,  our  results  are  incompatible  with  those  of  Fogler  et  d,I. (24),  which 
demonstrated that AM from C3H/HeN mice can be stained by FITC-LPS equally 
as well as can PEM, and that AM can be activated for tumor cytotoxicity  by LPS 
stimulation alone. The reason for this discrepancy is unclear. 
In the present report,  we have described a  marked difference between  LM 
and PM in the expression of LPS-binding sites on the cell surface. The biologic 
role played by the lack of LPS binding to LM in host defense mechanisms and 
the its mode of acquisition are under study. 
Summary 
Although peritoneal resident macrophages (PRM) or peritoneal exudate mac- 
rophages (PEM) were activated by lipopolysaccharide (LPS) to kill tumor ceils in 
vitro, lung macrophages (LM) obtained by mincing lung tissues or by harvesting 
bronchial lavage were not activated by LPS under any experimental conditions, 
i.e., different LPS concentrations, incubation times and cytotoxicity assay meth- 
ods. The unresponsiveness of LM to LPS was seen in all  of the mouse strains 
tested. Treatment of LM with indomethacin did not affect the unresponsiveness, 
although it greatly augmented the cytotoxicity  of PRM stimulated with LPS. LM 
treated in  vitro  with crude  lymphokines (LK) did  not  show  cytotoxicity, but 
became sensitive to  LPS and cytotoxic for tumor cells.  LM  treated first with 
crude LK and then with LPS were cytotoxic, but LM treated first with LPS and 
then with crude LK were not. The ability of crude LK to render LM respc, nsive 
to LPS was neutralized by rabbit anti-mouse 3' interferon (IFN-3') antiserum but 
not by anti-mouse IFN-(o~ + ~) antiserum. LM treated with recombinant murine 
IFN-3' became responsive to LPS and showed cytotoxicity. LM were resistant to 
direct toxicity of LPS under conditions in which significant populations of PRM 
and  PEM  died.  However,  LM  became  sensitive to  direct  toxicity of LPS  by 
treatment with crude LK or recombinant murine IFN-y. Fluorescence micros- 
copy  showed  that  almost  all  PRM  and  PEM  were  stained  with  fluorescein 
isothiocyanate (FITC)-LPS, while <5% of the LM were stained. Instead, ~60% 
of the  LM  treated  with the  crude  LK or  recombinant IFN-3,  for  20  h  were 
stained with FITC-LPS. Fluorescence-activated cell sorter (FACS) analysis con- 
firmed  this  result.  The  staining  of  IFN-3,  treated  LM  with  FITC-LPS  was 
inhibited  by  polymyxin B  or  unlabeled  LPS.  These  results  suggest  that  the 1458  LIPOPOLYSACCHARIDE  RECEPTOR  ON  MOUSE LUNG  MACROPHAGES 
defective responsiveness of LM to LPS is due to the lack or very low expression 
of LPS-binding sites on the cell surface and  that  in vitro treatment with  IFN-7 
brings about the expression of them and renders LM responsive to LPS. 
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